Cargando…
In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract
Background Okoubaka aubrevillei is used in traditional West African medicine and in homeopathy for treatment and prevention of several gastrointestinal problems. The aim of this in vitro study was to evaluate the effect of repeated doses of two Okoubaka products (10 % ethanolic tincture, mother ti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516495/ https://www.ncbi.nlm.nih.gov/pubmed/33979845 http://dx.doi.org/10.1055/a-1404-3344 |
_version_ | 1784583816175681536 |
---|---|
author | Buchheim-Schmidt, Susann Peters, Uwe Duysburgh, Cindy Van den Abbeele, Pieter Marzorati, Massimo Keller, Thomas Martin, David Klement, Petra Baumgartner, Stephan |
author_facet | Buchheim-Schmidt, Susann Peters, Uwe Duysburgh, Cindy Van den Abbeele, Pieter Marzorati, Massimo Keller, Thomas Martin, David Klement, Petra Baumgartner, Stephan |
author_sort | Buchheim-Schmidt, Susann |
collection | PubMed |
description | Background Okoubaka aubrevillei is used in traditional West African medicine and in homeopathy for treatment and prevention of several gastrointestinal problems. The aim of this in vitro study was to evaluate the effect of repeated doses of two Okoubaka products (10 % ethanolic tincture, mother tincture (MT); 3 (rd) decimal potency, 3X) on the microbial activity of physiological human colon microbiota using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME (®) ) and to investigate any preventive effect against infections with diarrhea-causing pathogens. Methods Upon inoculation with fecal microbiota from a healthy donor, 4 parallel proximal colon compartments of the SHIME were treated either with Okoubaka MT, Okoubaka 3X, ethanol control or blank control for 7 days. Using the Okoubaka -adapted microbial community from SHIME, 48 h challenge tests were performed with enterotoxigenic Escherichia coli (ETEC) and Salmonella enteritidis in 4 different doses (10 (3) –10 (8) colony forming units as typical in vivo infectious doses). Pathogen concentrations, short-chain fatty acids (SCFAs) and branched SCFA production were measured in triplicate at 0, 24 and 48 h. Results In the challenge tests, both Okoubaka products were able to restrict the colonization of ETEC and Salmonella at 3 of the 4 pathogen doses (except the highest doses), with a stronger anti-pathogenic effect for MT, which included a reduction of 2.0 log-units of ETEC (p < 0.0001) and 1.1 log-units of Salmonella (p < 0.0001). Total SCFA levels remained unaffected, but butyrate increased during the first 24 h (p < 0.0001 for ETEC), accompanied by decreased acetate production. Conclusion We observed in vitro a systemic activating effect of Okoubaka on intestinal microbiome resistance, which resulted in an anti-pathogenic effect, especially against ETEC. We hypothesize that the mode of action in vivo is also based on systemic regulative effects. |
format | Online Article Text |
id | pubmed-8516495 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-85164952021-10-15 In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract Buchheim-Schmidt, Susann Peters, Uwe Duysburgh, Cindy Van den Abbeele, Pieter Marzorati, Massimo Keller, Thomas Martin, David Klement, Petra Baumgartner, Stephan Z Gastroenterol Background Okoubaka aubrevillei is used in traditional West African medicine and in homeopathy for treatment and prevention of several gastrointestinal problems. The aim of this in vitro study was to evaluate the effect of repeated doses of two Okoubaka products (10 % ethanolic tincture, mother tincture (MT); 3 (rd) decimal potency, 3X) on the microbial activity of physiological human colon microbiota using a Simulator of the Human Intestinal Microbial Ecosystem (SHIME (®) ) and to investigate any preventive effect against infections with diarrhea-causing pathogens. Methods Upon inoculation with fecal microbiota from a healthy donor, 4 parallel proximal colon compartments of the SHIME were treated either with Okoubaka MT, Okoubaka 3X, ethanol control or blank control for 7 days. Using the Okoubaka -adapted microbial community from SHIME, 48 h challenge tests were performed with enterotoxigenic Escherichia coli (ETEC) and Salmonella enteritidis in 4 different doses (10 (3) –10 (8) colony forming units as typical in vivo infectious doses). Pathogen concentrations, short-chain fatty acids (SCFAs) and branched SCFA production were measured in triplicate at 0, 24 and 48 h. Results In the challenge tests, both Okoubaka products were able to restrict the colonization of ETEC and Salmonella at 3 of the 4 pathogen doses (except the highest doses), with a stronger anti-pathogenic effect for MT, which included a reduction of 2.0 log-units of ETEC (p < 0.0001) and 1.1 log-units of Salmonella (p < 0.0001). Total SCFA levels remained unaffected, but butyrate increased during the first 24 h (p < 0.0001 for ETEC), accompanied by decreased acetate production. Conclusion We observed in vitro a systemic activating effect of Okoubaka on intestinal microbiome resistance, which resulted in an anti-pathogenic effect, especially against ETEC. We hypothesize that the mode of action in vivo is also based on systemic regulative effects. Georg Thieme Verlag KG 2021-05-12 /pmc/articles/PMC8516495/ /pubmed/33979845 http://dx.doi.org/10.1055/a-1404-3344 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Buchheim-Schmidt, Susann Peters, Uwe Duysburgh, Cindy Van den Abbeele, Pieter Marzorati, Massimo Keller, Thomas Martin, David Klement, Petra Baumgartner, Stephan In vitro evaluation of the anti-pathogenic activity of Okoubaka aubrevillei on the human gastrointestinal tract |
title | In vitro
evaluation of the anti-pathogenic activity of
Okoubaka aubrevillei
on the human gastrointestinal tract
|
title_full | In vitro
evaluation of the anti-pathogenic activity of
Okoubaka aubrevillei
on the human gastrointestinal tract
|
title_fullStr | In vitro
evaluation of the anti-pathogenic activity of
Okoubaka aubrevillei
on the human gastrointestinal tract
|
title_full_unstemmed | In vitro
evaluation of the anti-pathogenic activity of
Okoubaka aubrevillei
on the human gastrointestinal tract
|
title_short | In vitro
evaluation of the anti-pathogenic activity of
Okoubaka aubrevillei
on the human gastrointestinal tract
|
title_sort | in vitro
evaluation of the anti-pathogenic activity of
okoubaka aubrevillei
on the human gastrointestinal tract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8516495/ https://www.ncbi.nlm.nih.gov/pubmed/33979845 http://dx.doi.org/10.1055/a-1404-3344 |
work_keys_str_mv | AT buchheimschmidtsusann invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT petersuwe invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT duysburghcindy invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT vandenabbeelepieter invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT marzoratimassimo invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT kellerthomas invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT martindavid invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT klementpetra invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract AT baumgartnerstephan invitroevaluationoftheantipathogenicactivityofokoubakaaubrevilleionthehumangastrointestinaltract |